The question is, what's really behind the mechanism, whether beta-amyloid or tau?

Five days later, Tweetbot released a beta version, but under restrictive terms.

Harris made clear that News, Sports and Travel are still in beta.

The start date for the open beta is yet to be confirmed.

Although both experimental drugs focus on the amyloid-beta protein, they work differently.